230 related articles for article (PubMed ID: 34124158)
1. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
Kantipudi S; Fotiadis D
Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
[TBL] [Abstract][Full Text] [Related]
2. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
[TBL] [Abstract][Full Text] [Related]
3. Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.
Kantipudi S; Harder D; Fotiadis D
Front Physiol; 2023; 14():1148055. PubMed ID: 36895635
[TBL] [Abstract][Full Text] [Related]
4.
Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
[TBL] [Abstract][Full Text] [Related]
5. Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993041
[TBL] [Abstract][Full Text] [Related]
6. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
[TBL] [Abstract][Full Text] [Related]
7. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
Jeckelmann JM; Fotiadis D
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
[TBL] [Abstract][Full Text] [Related]
8. LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.
Rossier G; Meier C; Bauch C; Summa V; Sordat B; Verrey F; Kühn LC
J Biol Chem; 1999 Dec; 274(49):34948-54. PubMed ID: 10574970
[TBL] [Abstract][Full Text] [Related]
9. Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties.
Khunweeraphong N; Nagamori S; Wiriyasermkul P; Nishinaka Y; Wongthai P; Ohgaki R; Tanaka H; Tominaga H; Sakurai H; Kanai Y
J Pharmacol Sci; 2012; 119(4):368-80. PubMed ID: 22850614
[TBL] [Abstract][Full Text] [Related]
10. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
[TBL] [Abstract][Full Text] [Related]
11. Transport of a neurotoxicant by molecular mimicry: the methylmercury-L-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2.
Simmons-Willis TA; Koh AS; Clarkson TW; Ballatori N
Biochem J; 2002 Oct; 367(Pt 1):239-46. PubMed ID: 12117417
[TBL] [Abstract][Full Text] [Related]
12. Differential expression and functional characterization of system L amino acid transporters in human normal osteoblast cells and osteogenic sarcoma cells.
Kim SG; Kim HH; Kim HK; Kim CH; Chun HS; Kanai Y; Endou H; Kim DK
Anticancer Res; 2006; 26(3A):1989-96. PubMed ID: 16827134
[TBL] [Abstract][Full Text] [Related]
13. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
14. The heterodimeric amino acid transporter 4F2hc/y+LAT2 mediates arginine efflux in exchange with glutamine.
Bröer A; Wagner CA; Lang F; Bröer S
Biochem J; 2000 Aug; 349 Pt 3(Pt 3):787-95. PubMed ID: 10903140
[TBL] [Abstract][Full Text] [Related]
15. Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.
Meury M; Costa M; Harder D; Stauffer M; Jeckelmann JM; Brühlmann B; Rosell A; Ilgü H; Kovar K; Palacín M; Fotiadis D
PLoS One; 2014; 9(10):e109882. PubMed ID: 25299125
[TBL] [Abstract][Full Text] [Related]
16. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.
Rosell A; Meury M; Álvarez-Marimon E; Costa M; Pérez-Cano L; Zorzano A; Fernández-Recio J; Palacín M; Fotiadis D
Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2966-71. PubMed ID: 24516142
[TBL] [Abstract][Full Text] [Related]
17. Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine.
Rajan DP; Kekuda R; Huang W; Devoe LD; Leibach FH; Prasad PD; Ganapathy V
Biochim Biophys Acta; 2000 Jan; 1463(1):6-14. PubMed ID: 10631289
[TBL] [Abstract][Full Text] [Related]
18. Expression and functional characterisation of System L amino acid transporters in the human term placenta.
Gaccioli F; Aye IL; Roos S; Lager S; Ramirez VI; Kanai Y; Powell TL; Jansson T
Reprod Biol Endocrinol; 2015 Jun; 13():57. PubMed ID: 26050671
[TBL] [Abstract][Full Text] [Related]
19. Expression of human heteromeric amino acid transporters in the yeast Pichia pastoris.
Costa M; Rosell A; Álvarez-Marimon E; Zorzano A; Fotiadis D; Palacín M
Protein Expr Purif; 2013 Jan; 87(1):35-40. PubMed ID: 23085088
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the amino acid transporters LAT1 and LAT2 in relation to the pharmacokinetics and side effects of melphalan.
Kühne A; Kaiser R; Schirmer M; Heider U; Muhlke S; Niere W; Overbeck T; Hohloch K; Trümper L; Sezer O; Brockmöller J
Pharmacogenet Genomics; 2007 Jul; 17(7):505-17. PubMed ID: 17558306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
